WAM
DWTX

Warberg Asset Management’s Dogwood Therapeutics DWTX Stock Holding History

Warberg Asset Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,990
Closed -$27.5K – 273
2023
Q1 		$27.5K Sell
2,990
-3,410
-53% -$27.1K 0.01% 162
2022
Q4 		$37.8K Sell
6,400
-1,600
-20% -$12.1K 0.01% 159
2022
Q3 		$74K Buy
+8,000
New +$1.13M 0.01% 162

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Warberg Asset Management's DWTX Position: Q2 2023 in Review

Warberg Asset Management sold out of Dogwood Therapeutics (DWTX) in Q2 2023, closing a stake of 2,990 shares — an estimated $27.5K sold.

Warberg Asset Management first reported a position in DWTX in Q3 2022 and held it in 3 quarters. The position peaked at $74K in Q3 2022. 24 funds tracked by Wall St. Rank hold DWTX as of Q2 2023.

  • Warberg Asset Management reported no remaining Dogwood Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Warberg Asset Management sold 2,990 Dogwood Therapeutics shares in Q2 2023, an estimated $27.5K.
  • Warberg Asset Management first reported a position in Dogwood Therapeutics in Q3 2022 and held it in 3 quarters.
  • Warberg Asset Management's Dogwood Therapeutics position peaked at $74K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2023.

Based on Warberg Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.